Age-Specific  	Age-Specific  	 JJ	B-NP
Gastric  	Gastric  	 NNP	I-NP
Cancer  	Cancer  	 NNP	I-NP
Risk  	Risk  	 NNP	I-NP
Indicated  	Indicated  	 NNP	O
by  	by  	 IN	O
the  	the  	 DT	O
Combination  	Combination  	 NNP	O
of  	of  	 IN	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 VBD	O
Sero-Status  	Sero-Status  	 JJ	B-NP
and  	and  	 CC	O
Serum  	Serum  	 NNP	B-NP
Pepsinogen  	Pepsinogen  	 NNP	I-NP
Levels  	Levels  	 NNP	I-NP
Serologic  	Serologic  	 NNP	I-NP
screening  	screening  	 NN	I-NP
of  	of  	 IN	O
gastric  	gastric  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
GC 	GC 	 NNP	B-NP
)  	)  	 -RRB-	O
by  	by  	 IN	O
serum  	serum  	 JJ	B-NP
pepsinogens  	pepsinogens  	 NNS	I-NP
( 	( 	 -LRB-	O
sPG 	sPG 	 NNP	B-NP
)  	)  	 -RRB-	O
levels  	levels  	 NNS	O
and  	and  	 CC	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 NNS	I-NP
( 	( 	 -LRB-	O
Hp 	Hp 	 NNP	B-NP
)  	)  	 -RRB-	O
sero-status 	sero-status 	 NNP	B-NP
,  	,  	 ,	O
though  	though  	 RB	O
highly  	highly  	 RB	O
informative 	informative 	 JJ	O
,  	,  	 ,	O
has  	has  	 VBZ	O
provided  	provided  	 VBN	O
heterogeneous  	heterogeneous  	 JJ	B-NP
results 	results 	 NNS	I-NP
.  	.  	 .	O
Here 	Here 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
evaluated  	evaluated  	 VBN	O
the  	the  	 DT	O
modifying  	modifying  	 JJ	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
demographic  	demographic  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	B-NP
impact  	impact  	 NN	I-NP
of  	of  	 IN	I-NP
Hp  	Hp  	 NNP	I-NP
sero-status 	sero-status 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
sPG  	sPG  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
gastric  	gastric  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
particular  	particular  	 JJ	O
emphasis  	emphasis  	 NN	O
on  	on  	 IN	O
age 	age 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
study  	study  	 NN	I-NP
was  	was  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
on  	on  	 IN	O
1341  	1341  	 CD	O
individuals  	individuals  	 NNS	O
( 	( 	 -LRB-	O
GC  	GC  	 NNP	B-NP
=  	=  	 SYM	O
578 	578 	 CD	O
,  	,  	 ,	O
healthy  	healthy  	 JJ	O
=  	=  	 CD	O
763 	763 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
who  	who  	 WP	O
were  	were  	 VBD	O
stratified  	stratified  	 VBN	O
into  	into  	 IN	O
two  	two  	 CD	O
age  	age  	 NN	B-NP
groups 	groups 	 NNS	I-NP
:  	:  	 :	O
35-59  	35-59  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
middle-aged 	middle-aged 	 JJ	O
,  	,  	 ,	O
n  	n  	 VBG	O
=  	=  	 SYM	O
830 	830 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
≥  	≥  	 CD	O
60  	60  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
60  	60  	 CD	O
years-plus 	years-plus 	 NN	B-NP
,  	,  	 ,	O
n  	n  	 VBG	O
=  	=  	 SYM	O
511 	511 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Demographic  	Demographic  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
serological  	serological  	 JJ	B-NP
states  	states  	 NNS	I-NP
( 	( 	 -LRB-	O
Hp  	Hp  	 NNP	B-NP
sero-staus  	sero-staus  	 NNP	I-NP
and  	and  	 CC	O
sPG  	sPG  	 JJ	B-NP
levels 	levels 	 NNS	I-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
by  	by  	 IN	O
subject  	subject  	 JJ	O
interview  	interview  	 NN	O
and  	and  	 CC	O
serum  	serum  	 JJ	B-NP
ELISAs 	ELISAs 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Covariate-specific  	Covariate-specific  	 JJ	B-NP
odds  	odds  	 NNS	I-NP
ratios  	ratios  	 NNS	I-NP
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
by  	by  	 IN	O
multivariable  	multivariable  	 JJ	B-NP
logistic  	logistic  	 JJ	I-NP
regression 	regression 	 NN	I-NP
.  	.  	 .	O
Hp  	Hp  	 JJ	B-NP
infection  	infection  	 NN	I-NP
was  	was  	 VBD	O
consistently  	consistently  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
sPGI  	sPGI  	 JJ	O
and  	and  	 CC	O
sPGII  	sPGII  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
60  	60  	 CD	O
year-plus 	year-plus 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
the  	the  	 DT	O
middle-aged  	middle-aged  	 JJ	O
group 	group 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
joint  	joint  	 JJ	O
examination  	examination  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
variable  	variable  	 JJ	O
states  	states  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
serum  	serum  	 CD	B-NP
biomarkers  	biomarkers  	 NNS	I-NP
( 	( 	 -LRB-	O
Hp  	Hp  	 NNP	B-NP
serology 	serology 	 NN	I-NP
,  	,  	 ,	O
sPGI 	sPGI 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
sPGI 	sPGI 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
II  	II  	 NNP	I-NP
ratio 	ratio 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
60  	60  	 CD	O
year-plus  	year-plus  	 JJ	B-NP
age  	age  	 NN	I-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
demonstrated  	demonstrated  	 VBD	O
a  	a  	 DT	O
stepwise  	stepwise  	 JJ	B-NP
escalation  	escalation  	 NN	I-NP
of  	of  	 IN	O
risk  	risk  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
single  	single  	 JJ	O
( 	( 	 -LRB-	O
sPGI  	sPGI  	 JJ	B-NP
low 	low 	 JJ	I-NP
;  	;  	 :	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
2.6 	2.6 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
to  	to  	 TO	O
double  	double  	 VB	O
( 	( 	 -LRB-	O
sPGI  	sPGI  	 JJ	B-NP
low 	low 	 JJ	I-NP
/ 	/ 	 NNP	I-NP
sPGI 	sPGI 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
II  	II  	 NNP	I-NP
low 	low 	 JJ	I-NP
;  	;  	 :	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
3.55 	3.55 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
Hp  	Hp  	 NNP	B-NP
positive 	positive 	 JJ	I-NP
/ 	/ 	 CD	I-NP
sPGI  	sPGI  	 JJ	I-NP
low 	low 	 JJ	I-NP
;  	;  	 :	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
5.0 	5.0 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
ultimately  	ultimately  	 RB	O
triple  	triple  	 JJ	O
( 	( 	 -LRB-	O
Hp  	Hp  	 FW	B-NP
positive 	positive 	 FW	I-NP
/ 	/ 	 FW	I-NP
PGI  	PGI  	 FW	I-NP
low 	low 	 FW	I-NP
/ 	/ 	 FW	I-NP
PGI 	PGI 	 FW	I-NP
/ 	/ 	 FW	I-NP
II  	II  	 NNP	I-NP
low 	low 	 JJ	O
;  	;  	 :	O
OR  	OR  	 NNP	O
=  	=  	 SYM	O
10.48 	10.48 	 CD	O
)  	)  	 -RRB-	O
positive  	positive  	 JJ	B-NP
states 	states 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
reference  	reference  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
triple  	triple  	 JJ	O
negatives 	negatives 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
pattern  	pattern  	 NN	O
was  	was  	 VBD	O
not  	not  	 RB	O
exhibited  	exhibited  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
middle-aged  	middle-aged  	 JJ	O
subjects 	subjects 	 NNS	B-NP
.  	.  	 .	O
Age  	Age  	 NN	O
was  	was  	 VBD	O
clearly  	clearly  	 RB	O
identified  	identified  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
modifying  	modifying  	 JJ	O
factor  	factor  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	B-NP
projection  	projection  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
combined  	combined  	 JJ	O
states  	states  	 NNS	O
of  	of  	 IN	O
Hp  	Hp  	 NNP	B-NP
serology  	serology  	 NN	I-NP
and  	and  	 CC	O
sPG  	sPG  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
gastric  	gastric  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
screening 	screening 	 NN	I-NP
,  	,  	 ,	O
reflected  	reflected  	 VBD	O
by  	by  	 IN	O
the  	the  	 DT	O
augmented  	augmented  	 NN	O
( 	( 	 -LRB-	O
~10.5  	~10.5  	 FW	O
fold 	fold 	 FW	O
)  	)  	 -RRB-	O
risk  	risk  	 NN	O
of  	of  	 IN	O
GC  	GC  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
triple  	triple  	 JJ	O
positive  	positive  	 JJ	O
( 	( 	 -LRB-	O
Hp  	Hp  	 FW	B-NP
positive 	positive 	 FW	I-NP
/ 	/ 	 FW	I-NP
sPGI  	sPGI  	 FW	I-NP
low 	low 	 FW	I-NP
/ 	/ 	 FW	I-NP
sPGI 	sPGI 	 FW	I-NP
/ 	/ 	 FW	I-NP
II  	II  	 NNP	I-NP
low 	low 	 JJ	O
)  	)  	 -RRB-	O
60  	60  	 CD	O
year-plus  	year-plus  	 JJ	B-NP
subjects 	subjects 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
not  	not  	 RB	O
evident  	evident  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
middle-aged  	middle-aged  	 JJ	O
group 	group 	 NN	O
.  	.  	 .	O
